{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T09:44:13Z","timestamp":1766137453827,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.vaccine.2020.05.053","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T03:41:56Z","timestamp":1590810116000},"page":"4829-4836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluating the population measles susceptibility in Tianjin, China"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4037-5467","authenticated-orcid":false,"given":"Yaxing","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naiying","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6936-2320","authenticated-orcid":false,"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2020.05.053_b0005","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/21645515.2018.1517074","article-title":"Measles vaccination in an increasingly immunized and developed world","volume":"15","author":"Hayman","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"10.1016\/j.vaccine.2020.05.053_b0010","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3949\/ccjm.86a.19065","article-title":"Measles: A dangerous vaccine-preventable disease returns","volume":"86","author":"Porter","year":"2019","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.vaccine.2020.05.053_b0015","first-page":"jiaa044","article-title":"The Changing Global Epidemiology of Measles, 2013-2018","volume":"pii","author":"Patel","year":"2020","journal-title":"J Infect Dis"},{"issue":"48","key":"10.1016\/j.vaccine.2020.05.053_b0020","first-page":"1105","article-title":"Progress Toward Regional Measles Elimination - Worldwide, 2000\u20132018","volume":"68","author":"Patel","year":"2019","journal-title":"MMWR"},{"issue":"48","key":"10.1016\/j.vaccine.2020.05.053_b0025","first-page":"1112","article-title":"Progress Toward Measles Elimination - China, January 2013-June 2019","volume":"68","author":"Ma","year":"2019","journal-title":"MMWR"},{"issue":"16","key":"10.1016\/j.vaccine.2020.05.053_b0030","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1016\/j.vaccine.2020.03.006","article-title":"Risk factors for measles virus infection and susceptibility in persons aged 15 years and older in China: A multi-site case-control study, 2012\u20132013","volume":"38","author":"Ma","year":"2020","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2020.05.053_b0035","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3390\/v11080765","article-title":"Measles Elimination: Identifying Susceptible Sub-Populations to Tailor Immunization Strategies","volume":"11","author":"Kreidl","year":"2019","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.vaccine.2020.05.053_b0040","first-page":"804","article-title":"Measles Virus IgG Avidity Assay for Use in Identification of Measles Vaccine Failures in Tianjin, China","volume":"32","author":"Ding","year":"2019","journal-title":"Biomed Environ Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2020.05.053_b0045","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1096-9071(199707)52:3<275::AID-JMV7>3.0.CO;2-#","article-title":"Enzyme-linked immunosorbent assay-IgG antibody avidity test for single sample serologic evaluation of measles vaccines","volume":"52","author":"de Souza","year":"1997","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2020.05.053_b0050","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1017\/S0950268899003222","article-title":"Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age","volume":"124","author":"Paunio","year":"2000","journal-title":"Epidemiol Infect"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.05.053_b0055","doi-asserted-by":"crossref","first-page":"S549","DOI":"10.1093\/infdis\/jir106","article-title":"Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals","volume":"204","author":"Hickman","year":"2011","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2020.05.053_b0060","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2471\/BLT.13.130195","article-title":"Monitoring progress towards the elimination of measles in China: an analysis of measles surveillance data","volume":"92","author":"Ma","year":"2014","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2020.05.053_b0065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijid.2018.10.023","article-title":"A hospital-associated measles outbreak in health workers in Beijing: implications for measles elimination in China, 2018","volume":"78","author":"Fu","year":"2019","journal-title":"Int J Infect Dis"},{"issue":"33","key":"10.1016\/j.vaccine.2020.05.053_b0070","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1016\/j.vaccine.2017.06.058","article-title":"An increasing, potentially measles-susceptible population over time after vaccination in Korea","volume":"35","author":"Kang","year":"2017","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2020.05.053_b0075","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1517\/14656566.4.8.1215","article-title":"IgG avidity to distinguish secondary from primary measles vaccination failures: prospects for a more effective global measles elimination strategy","volume":"4","author":"Paunio","year":"2003","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"10.1016\/j.vaccine.2020.05.053_b0080","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/microorganisms8020276","article-title":"Measles: An Overview of a Re-Emerging Disease in Children and Immunocompromised Patients","volume":"8","author":"Misin","year":"2020","journal-title":"Microorganisms"},{"issue":"27","key":"10.1016\/j.vaccine.2020.05.053_b0085","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1016\/j.vaccine.2016.04.094","article-title":"A population profile of measles susceptibility in Tianjin, China","volume":"34","author":"Boulton","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.05.053_b0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijid.2016.03.005","article-title":"The impact of supplementary immunization activities on the epidemiology of measles in Tianjin, China","volume":"45","author":"Wagner","year":"2016","journal-title":"Int J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2020.05.053_b0095","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.vaccine.2017.01.010","article-title":"Interpreting the transmissibility of measles in two different post periods of supplementary immunization activities in Hubei, China","volume":"35","author":"Chong","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.05.053_b0100","doi-asserted-by":"crossref","first-page":"e0170257","DOI":"10.1371\/journal.pone.0170257","article-title":"Decreasing seroprevalence of Measles antibodies after vaccination - possible gap in measles protection in adults in the Czech Republic","volume":"12","author":"Smetana","year":"2017","journal-title":"PLoS ONE"},{"issue":"36","key":"10.1016\/j.vaccine.2020.05.053_b0105","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1016\/j.vaccine.2019.07.075","article-title":"Study on factors associated with seroprotection after measles vaccination in children of 6\u201314 years in Eastern China","volume":"37","author":"Yan","year":"2019","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2020.05.053_b0110","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.vaccine.2015.11.006","article-title":"A measles outbreak in a middle school with high vaccination coverage and evidence of prior immunity among cases, Beijing, P.R. China","volume":"34","author":"Ma","year":"2016","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2020.05.053_b0115","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1128\/CVI.00406-12","article-title":"Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings","volume":"19","author":"Mercader","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"51","key":"10.1016\/j.vaccine.2020.05.053_b0120","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1016\/j.vaccine.2016.02.051","article-title":"Measles transmission among adults with spread to children during an outbreak: Implications for measles elimination in China, 2014","volume":"34","author":"Ma","year":"2016","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2020.05.053_b0125","doi-asserted-by":"crossref","first-page":"e0168222","DOI":"10.1371\/journal.pone.0168222","article-title":"Investigation of a Measles Outbreak in China to Identify Gaps in Vaccination Coverage, Routes of Transmission, and Interventions","volume":"11","author":"Zheng","year":"2016","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.vaccine.2020.05.053_b0130","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/ije\/dyz058","article-title":"Evaluating vaccination policies to accelerate measles elimination in China: a meta-population modelling study","volume":"48","author":"Hao","year":"2019","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.05.053_b0135","doi-asserted-by":"crossref","first-page":"16124","DOI":"10.1038\/s41598-018-34461-0","article-title":"Targeting Adults for Supplementary Immunization Activities of Measles Control in Central China: A Mathematical Modelling Study","volume":"8","author":"Chong","year":"2018","journal-title":"Sci Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20306988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20306988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:44:28Z","timestamp":1759401868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20306988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":27,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0264410X20306988"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the population measles susceptibility in Tianjin, China","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}